D. Brown et al., A PMLRAR-ALPHA TRANSGENE INITIATES MURINE ACUTE PROMYELOCYTIC LEUKEMIA, Proceedings of the National Academy of Sciences of the United Statesof America, 94(6), 1997, pp. 2551-2556
The malignant cells of acute promyelocytic leukemia (APL) contain a re
ciprocal chromosomal translocation that fuses the promyelocytic leukem
ia gene (PML) with the retinoic acid receptor alpha gene (RAR alpha).
To test the hypothesis that the chimera PMLRAR alpha plays a role in l
eukemogenesis, we expressed a PMLRAR alpha cDNA in myeloid cells of tr
ansgenic mice, PMLRAR alpha transgenic mice exhibited impaired neutrop
hil maturation early in life, which progressed at a low frequency over
the course of several months to overt APL, Both the preleukemic state
and the leukemia could be transplanted to nontransgenic mice, and the
transplanted preleukemia could progress to APL, The APL recapitulated
features of the human disease, including a response to retinoic acid,
Retinoic acid caused the leukemic cells to differentiate in vitro and
in vivo, eliciting remissions of both the preleukemic state and APL i
n mice, Our results demonstrate that PMLRAR alpha impairs neutrophil d
ifferentiation and initiates the development of APL, The transgenic mi
ce described here provide an apparently accurate model for human APL t
hat includes clear evidence of tumor progression, The model should be
useful for exploring the molecular pathogenesis of APL and the mechani
sms of the therapeutic response to retinoic acid, as well as for precl
inical studies of therapeutic regimens.